PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
Jacob LønborgReza JabbariMuhammad SabbahKarsten T VeienMatti NiemeläPhillip FreemanRickard LinderDan IoanesChristian J TerkelsenOlli A KajanderSasha KoulMikko SavontausPasi KarjalainenAndrejs ErglisMikko MinkkinenRikke SørensenHans-Henrik TilstedLene HolmvangGintautas BieliauskasJulia EllertJarkko PiuholaAshkan EftekhariOskar AngeråsAndreas RückEvald H ChristiansenTroels JørgensenBurcu T ÖzbekCharlotte GlingeLars SøndergaardOle De BackerThomas Engstrømnull nullPublished in: The New England journal of medicine (2024)
Among patients with coronary artery disease who were undergoing TAVI, PCI was associated with a lower risk of a composite of death from any cause, myocardial infarction, or urgent revascularization at a median follow-up of 2 years than conservative treatment. (Funded by Boston Scientific and the Danish Heart Foundation; NOTION-3 ClinicalTrials.gov number, NCT03058627.).
Keyphrases
- transcatheter aortic valve implantation
- percutaneous coronary intervention
- aortic valve
- aortic valve replacement
- aortic stenosis
- patients undergoing
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- heart failure
- coronary artery bypass grafting
- antiplatelet therapy
- st elevation myocardial infarction
- st segment elevation myocardial infarction
- atrial fibrillation
- left ventricular
- transcatheter aortic valve replacement
- ejection fraction
- replacement therapy
- coronary artery bypass